Endocrine System / Perimenopause / PRP / Greene Climacteric Scale - EU

This Circle helps physicians capture and monetize real-world data from their everyday delivery of PRP treatments tailored for perimenopausal women.

The Platelet Rich Plasma “PRP” Market was valued at about $480 million in 2023 and is projected to reach about $1.2 billion by 2032. Perimenopause presents a unique opportunity for PRP therapies, addressing a variety of health and wellness concerns specific to this demographic, such as skin rejuvenation, hair restoration, and improving vaginal health. As demand grows, manufacturers will increasingly seek real-world safety and efficacy data to enhance product development and regulatory approvals.

This Circle helps physicians obtain and aggregate high-quality real-world data from perimenopausal treatments that companies are actively seeking. Participation is minimally burdensome, and members will receive recurring license fees based on their contribution of treatment cases, outcomes, and other relevant data.